LLY
902.74
-0.9%↓
UNH
596.8
+0.31%↑
NVO
131.05
+0.18%↑
JNJ
164.37
-0.29%↓
ABBV
193.18
+0.34%↑
LLY
902.74
-0.9%↓
UNH
596.8
+0.31%↑
NVO
131.05
+0.18%↑
JNJ
164.37
-0.29%↓
ABBV
193.18
+0.34%↑
LLY
902.74
-0.9%↓
UNH
596.8
+0.31%↑
NVO
131.05
+0.18%↑
JNJ
164.37
-0.29%↓
ABBV
193.18
+0.34%↑
LLY
902.74
-0.9%↓
UNH
596.8
+0.31%↑
NVO
131.05
+0.18%↑
JNJ
164.37
-0.29%↓
ABBV
193.18
+0.34%↑
LLY
902.74
-0.9%↓
UNH
596.8
+0.31%↑
NVO
131.05
+0.18%↑
JNJ
164.37
-0.29%↓
ABBV
193.18
+0.34%↑
Ülevaade
Aktsiahinna muutus
24h
Praegune
Min
82.94
Max
83.26
Soovitused | Tugev "osta" hinnang |
---|---|
12 kuu keskmine prognoos | +6.27 upside |
Tehniline skoor
By Trading Central
Kindlus
Very Strong Bearish Evidence
82.46 / 87.21 Toetus ja vastupanu
AstraZeneca PLC ADR Graafik
Seotud uudised
25. juuli 2024, 09:17 UTC
AstraZeneca Raises Guidance After Results Beat Market Expectations -- Update
DJ
Loe
25. juuli 2024, 06:48 UTC
AstraZeneca Raises Guidance After Revenue, Earnings Beat Market Expectations
DJ
Loe
12. juuli 2024, 19:57 UTC
Instil Bio Shares Surge Following Rental Agreement with AstraZeneca
DJ
Loe
5. sept 2024, 13:00 UTC
China Detains AstraZeneca Employees Over Alleged Transport of Unapproved Drug -- WSJ
DJ
Loe
29. juuli 2024, 10:30 UTC
Big Pharma Rallies and Moves Past Obesity -- Heard on the Street -- WSJ
DJ
Loe
25. juuli 2024, 13:20 UTC
AstraZeneca Slides Despite Beating Quarterly Expectations And Hiking Its Outlook -- IBD
DJ
Loe
25. juuli 2024, 09:21 UTC
AstraZeneca's Guidance Lift Is Conservative; Risks to Upside -- Market Talk
DJ
Loe
25. juuli 2024, 07:05 UTC
AstraZeneca Guidance Raise Signals Portfolio Potential -- Market Talk
DJ
Loe
25. juuli 2024, 06:06 UTC
AstraZeneca Increased Interim Dividend by 7c to $1.00
DJ
Loe
25. juuli 2024, 06:04 UTC
AstraZeneca Had Seen Core EPS Grow by Low Double-Digit to Low Teens Percentage Range
DJ
Loe
25. juuli 2024, 06:04 UTC
AstraZeneca Had Seen Total Revenue Grow by Low Double-Digit to Low Teens Percentage Range
DJ
Loe
25. juuli 2024, 06:04 UTC
AstraZeneca Sees Core EPS Growth in 2024 by Mid Teens Percentage Range At Constant Currency
DJ
Loe
25. juuli 2024, 06:04 UTC
AstraZeneca Sees Total Revenue Growth in 2024 by Mid Teens Percentage Range At Constant Currency
DJ
Loe
25. juuli 2024, 06:03 UTC
AstraZeneca Raises 2024 View
DJ
Loe
25. juuli 2024, 06:02 UTC
AstraZeneca 2Q Revenue Consensus Was $12.7B
DJ
Loe
25. juuli 2024, 06:02 UTC
AstraZeneca 2Q Core EPS Consensus Was $1.95
DJ
Loe
25. juuli 2024, 06:00 UTC
AstraZeneca PLC 2Q Adj EPS $1.98
DJ
Loe
25. juuli 2024, 06:00 UTC
AstraZeneca PLC 2Q Pretax Pft $2.4B
DJ
Loe
25. juuli 2024, 06:00 UTC
AstraZeneca PLC 2Q Rev $12.94B
DJ
Loe
25. juuli 2024, 06:00 UTC
AstraZeneca PLC 2Q Oper Pft $2.75B
DJ
Loe
25. juuli 2024, 06:00 UTC
AstraZeneca PLC 2Q Net Pft $1.93B
DJ
Loe
25. juuli 2024, 06:00 UTC
AstraZeneca PLC 2Q EPS $1.24
DJ
Loe
15. juuli 2024, 06:04 UTC
AstraZeneca: Amolyt Pharma's Hldrs Eligible to Receive $250M On Achieving Specific Milestone
DJ
Loe
15. juuli 2024, 06:04 UTC
AstraZeneca: Amolyt Pharma's Hldrs Eligible to Receive $250M On Achieving Specific Milestone
DJ
Loe
15. juuli 2024, 06:02 UTC
AstraZeneca: Acquisition Includes $800M Upfront at Deal Closing
DJ
Loe
15. juuli 2024, 06:02 UTC
AstraZeneca: Amolyt Pharma's Total Consideration of Up to $1.05B
DJ
Loe
15. juuli 2024, 06:01 UTC
AstraZeneca: Acquisition Bolsters Alexion Rare Disease Late-Stage Pipeline
DJ
Loe
15. juuli 2024, 06:00 UTC
AstraZeneca Completes Acquisition of Amolyt Pharma
DJ
Loe
15. juuli 2024, 06:00 UTC
AstraZeneca PLC Acquisition of Amolyt Pharma completed
DJ
Loe
15. juuli 2024, 06:00 UTC
AstraZeneca PLC Acquisition of Amolyt Pharma completed
DJ
Loe
Võrdlus sarnastega
Hinnamuutus
AstraZeneca PLC ADR Prognoos
Hinnasiht
By TipRanks
12 kuu keskmine prognoos
Keskmine 88.26 USD 6.27%
Kõrge 99 USD
Madal 74 USD
Põhineb 6 Wall Streeti analüütiku instrumendi AstraZeneca PLC ADR 12 kuu hinnasihil - viimase 3 kuu andmed.
Hinnangu Konsensus
By TipRanks
Tugev "osta" hinnang
6 ratings
5
Osta
1
Hoia
0
Müü
Põhineb 6 analüütiku instrumendi AstraZeneca PLC ADR aktsia reitingul - viimase 3 kuu andmed.
Tehniline skoor
By Trading Central
Lühikene perspektiiv
Very Strong Bearish Evidence
Recent bearish events outweigh bullish events.
Keskpikk perspektiiv
Bearish Evidence
Recent bearish events outweigh bullish events.
Pikk perspektiiv
No Evidence
There are no events.